| ISIN | IE00BK5H8015 |
|---|---|
| Valor Number | 49894453 |
| Bloomberg Global ID | |
| Fund Name | SPDR® STOXX Europe 600 SRI UCITS ETF EUR Unhedged (Acc) |
| Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
| Fund Provider | State Street Investment Management |
| Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Ireland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The investment objective of the Fund is to track the performance of European equities. |
| Peculiarities |
| Current Price * | 34.43 EUR | 15.12.2025 |
|---|---|---|
| Previous Price * | 34.14 EUR | 12.12.2025 |
| 52 Week High * | 34.42 EUR | 15.12.2025 |
| 52 Week Low * | 28.37 EUR | 09.04.2025 |
| NAV * | 34.43 EUR | 15.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 520,951,849 | |
| Unit/Share Assets *** | 520,951,849 | |
| Trading Information SIX | ||
| YTD Performance | +12.76% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | +12.05% |
31.12.2024 - 15.12.2025
31.12.2024 15.12.2025 |
| 1 month | +2.77% |
17.11.2025 - 15.12.2025
17.11.2025 15.12.2025 |
| 3 months | +5.43% |
15.09.2025 - 15.12.2025
15.09.2025 15.12.2025 |
| 6 months | +4.87% |
16.06.2025 - 15.12.2025
16.06.2025 15.12.2025 |
| 1 year | +9.90% |
16.12.2024 - 15.12.2025
16.12.2024 15.12.2025 |
| 2 years | +25.36% |
15.12.2023 - 15.12.2025
15.12.2023 15.12.2025 |
| 3 years | +46.22% |
15.12.2022 - 15.12.2025
15.12.2022 15.12.2025 |
| 5 years | +67.63% |
15.12.2020 - 15.12.2025
15.12.2020 15.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 6.28% | |
|---|---|---|
| AstraZeneca PLC | 4.37% | |
| Roche Holding AG | 4.08% | |
| Nestle SA | 3.90% | |
| Novartis AG Registered Shares | 3.81% | |
| SAP SE | 3.75% | |
| Allianz SE | 2.54% | |
| Novo Nordisk AS Class B | 2.41% | |
| Schneider Electric SE | 2.36% | |
| Unilever PLC | 2.31% | |
| Last data update | 30.11.2025 | |
| TER *** | 0.12% |
|---|---|
| TER date *** | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.12% |
| Ongoing Charges *** | 0.12% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |